Quick Answer
Emmaus Life Sciences, Inc. reported R&D Expense of $313.0 thousand for fiscal year 2025.
Emmaus Life Sciences, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $313.0K | -52.4% |
| 2024 | $657.0K | -44.7% |
| 2023 | $1.19M | -31.1% |
| 2022 | $1.73M | -58.0% |
| 2021 | $4.11M | +70.7% |
| 2020 | $2.41M | +10.3% |
| 2019 | $2.18M | +26.7% |
| 2018 | $1.72M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $50.0K | -65.8% | -10.7% |
| June 30, 2025 | $56.0K | -70.7% | -68.2% |
| March 31, 2025 | $176.0K | -3.8% | +20.5% |
| September 30, 2024 | $146.0K | -64.7% | -23.6% |
| June 30, 2024 | $191.0K | -40.3% | +4.4% |
| March 31, 2024 | $183.0K | -36.7% | -55.8% |
| September 30, 2023 | $414.0K | -4.2% | +29.4% |
| June 30, 2023 | $320.0K | +7.4% | +10.7% |
- Emmaus Life Sciences, Inc. showed a decrease of -52.4% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, Emmaus Life Sciences, Inc.’s r&d expense has declined by 81.8% (from $1.72 million to $313.0 thousand).
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: